Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 46.15B | 44.99B | 46.59B | 46.70B | 47.27B |
Gross Profit | 4.42B | 3.60B | 3.54B | 3.75B | 3.53B |
EBITDA | 3.71B | 2.94B | 2.93B | 3.17B | 3.06B |
Net Income | 1.12B | 416.00M | 316.00M | 465.00M | 475.00M |
Balance Sheet | |||||
Total Assets | 36.91B | 36.89B | 37.69B | 39.11B | 41.05B |
Cash, Cash Equivalents and Short-Term Investments | 2.33B | 1.97B | 2.23B | 1.84B | 2.94B |
Total Debt | 370.00M | 1.37B | 2.51B | 4.43B | 5.71B |
Total Liabilities | 11.21B | 11.88B | 13.21B | 14.99B | 17.20B |
Stockholders Equity | 25.42B | 24.73B | 24.16B | 23.78B | 23.56B |
Cash Flow | |||||
Free Cash Flow | 1.34B | 985.00M | 2.43B | 217.00M | 216.00M |
Operating Cash Flow | 3.25B | 2.59B | 3.46B | 2.18B | 2.74B |
Investing Cash Flow | -1.73B | -1.27B | -918.00M | -1.98B | -2.40B |
Financing Cash Flow | -1.30B | -1.46B | -2.19B | -1.51B | -773.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥12.94B | 11.60 | 2.90% | 2.56% | 168.27% | ||
74 Outperform | ¥5.85B | 12.55 | 1.87% | 4.81% | -6.89% | ||
72 Outperform | ¥18.09B | 7.84 | 2.60% | 1.73% | -2.77% | ||
70 Outperform | ¥7.23B | 7.54 | 1.96% | 1.73% | -61.62% | ||
70 Outperform | ¥23.43B | 9.81 | 3.06% | 3.60% | 16.83% | ||
67 Neutral | £2.82B | 10.43 | 4.69% | 234.75% | 2.73% | -20.52% | |
62 Neutral | ¥3.90B | 36.13 | 0.78% | 0.09% | 76.84% |